Photo from Michael Hofman/X
Jun 11, 2024, 06:42
Michael Hofman: Oliver Sartor presenting PSMAfore at SNMMI
Michael Hofman, Nuclear Medicine Physician at Melbourne’s Peter MacCallum Cancer Centre, shared a post on X/Twitter:
”Oliver Sartor presenting PSMAfore at SNMMI.
All efficacy endpoints favour Lu-PSMA617: better efficacy, quality of life, less side effects. Except, no difference in overall survival.”
Source: Michael Hofman/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 2, 2025, 19:03
Apr 2, 2025, 18:42
Apr 2, 2025, 18:29
Apr 2, 2025, 18:23
Apr 2, 2025, 18:14
Apr 2, 2025, 18:01
Apr 2, 2025, 17:58